Radiation Oncology/Therapy: Page 64

ESTRO33: Canadians develop genetic test for prostate risk
By AuntMinnieEurope.com staff writers
A new test can suss out the particular genetic signature of higher risk for prostate cancer in some individuals, according to a study presented Saturday at the conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna.
April 4, 2014
Accuray targets EIMEA region
By AuntMinnieEurope.com staff writers
Radiation oncology firm Accuray continues to expand its installed base in the Europe, India, Middle East, and Africa (EIMEA) region.
April 3, 2014
Innsbruck begins Elekta radiation therapy
By AuntMinnieEurope.com staff writers
Medical University Innsbruck has become the first medical center in Austria to begin treating patients with the Elekta Versa HD radiation therapy system, according to radiation oncology firm Elekta.
April 1, 2014
Varian extends pact with Paul Scherrer Institute
By AuntMinnieEurope.com staff writers
Varian Medical Systems and the Paul Scherrer Institute of Switzerland are extending their proton therapy collaboration.
April 1, 2014
Elekta to launch Esteya at ESTRO33
By AuntMinnieEurope.com staff writers
Radiation oncology firm Elekta plans to use the European Society for Radiotherapy and Oncology's (ESTRO) annual meeting in Vienna next week for the European launch of its Esteya electronic brachytherapy system for treating skin cancer.
April 1, 2014
U.K. issues new guidance on cancer imaging
By Philip Ward
The U.K. Royal College of Radiologists (RCR) has published updated recommendations for cross-sectional imaging in cancer management. They can be downloaded free of charge from the RCR's website.
March 31, 2014
2014 03 31 13 43 37 936 Cancer Cell Yellow 200
Biomarkers may predict radiotherapy's effectiveness in head and neck
By AuntMinnieEurope.com staff writers
Researchers have identified two biomarkers that may predict the effectiveness of radiation treatments for patients with head and neck cancer, according to a study in the European Journal of Cancer.
March 30, 2014
Eckert & Ziegler posts 2013 sales decreases
By AuntMinnieEurope.com staff writers
Isotope technology firm Eckert & Ziegler has posted a decrease in sales for its fiscal year 2013, although the company remains optimistic for its 2014 outlook.
March 27, 2014
IBA completes deal with University Hospital of Essen
By AuntMinnieEurope.com staff writers
Radiopharmaceutical provider Ion Beam Applications (IBA) has divested its ownership interest in a proton therapy center at the University Hospital of Essen.
March 26, 2014
Focused ultrasound therapy continues to progress
By AuntMinnieEurope.com staff writers
Tumor removal without a scalpel or x-rays is now possible due to a special type of focused ultrasound therapy developed by a new European Union project.
March 25, 2014
IBA sees drop in fiscal 2013 revenues
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) experienced a drop in revenue from sales and services for fiscal year 2013.
March 25, 2014
Sirtex and Guerbet to collaborate
By AuntMinnieEurope.com staff writers
Sirtex Medical and Guerbet are collaborating to advance research in the interventional treatment of primary and secondary metastatic liver cancer.
March 23, 2014
Previous Page
Page 64 of 127
Next Page